GMNCX | RSLEX | GMNCX / RSLEX | |
Total Expense Ratio | 0.90 | 1.00 | 90% |
Annual Report Gross Expense Ratio | 10.15 | 1.00 | 1,015% |
Fund Existence | 7 years | 23 years | - |
Gain YTD | -6.709 | -2.605 | 258% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 250 | 4,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.3M | 71.3B | 0% |
Annual Yield % from dividends | 1.00 | 0.66 | 152% |
Returns for 1 year | -5.77 | 1.06 | -543% |
Returns for 3 years | 4.75 | 8.28 | 57% |
Returns for 5 years | 57.07 | 30.62 | 186% |
Returns for 10 years | N/A | 36.72 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LADCX | 8.89 | 0.26 | +3.01% |
Lord Abbett Developing Growth C | |||
CCSGX | 24.94 | 0.42 | +1.71% |
Conestoga SMid Cap Institutional | |||
MEMCX | 31.45 | 0.52 | +1.68% |
MFS Emerging Markets Equity C | |||
GVALX | 13.85 | 0.21 | +1.54% |
Gotham Large Value Institutional | |||
FAVAX | 23.24 | 0.31 | +1.35% |
Fidelity Advisor Equity Value A |